nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—SIGMAR1—Progesterone—uterine cancer	0.145	0.208	CbGbCtD
Amiodarone—CYP2A6—Progesterone—uterine cancer	0.0602	0.0864	CbGbCtD
Amiodarone—CYP1A1—Progesterone—uterine cancer	0.0514	0.0738	CbGbCtD
Amiodarone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0448	0.0643	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0411	0.0591	CbGbCtD
Amiodarone—CYP3A7—Progesterone—uterine cancer	0.0411	0.0591	CbGbCtD
Amiodarone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0312	0.0449	CbGbCtD
Amiodarone—CYP3A5—Progesterone—uterine cancer	0.0309	0.0443	CbGbCtD
Amiodarone—CYP2C8—Progesterone—uterine cancer	0.0297	0.0426	CbGbCtD
Amiodarone—CYP2C19—Progesterone—uterine cancer	0.0249	0.0357	CbGbCtD
Amiodarone—CYP1A2—Progesterone—uterine cancer	0.023	0.033	CbGbCtD
Amiodarone—CYP2C9—Progesterone—uterine cancer	0.0207	0.0297	CbGbCtD
Amiodarone—ABCB1—Progesterone—uterine cancer	0.0201	0.0288	CbGbCtD
Amiodarone—CYP2D6—Progesterone—uterine cancer	0.0189	0.0272	CbGbCtD
Amiodarone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0182	0.0261	CbGbCtD
Amiodarone—ABCB1—Dactinomycin—uterine cancer	0.0159	0.0229	CbGbCtD
Amiodarone—CYP3A5—Etoposide—uterine cancer	0.0138	0.0198	CbGbCtD
Amiodarone—CYP2C8—Etoposide—uterine cancer	0.0133	0.0191	CbGbCtD
Amiodarone—CYP3A4—Progesterone—uterine cancer	0.012	0.0173	CbGbCtD
Amiodarone—CYP1A2—Etoposide—uterine cancer	0.0103	0.0148	CbGbCtD
Amiodarone—ABCB1—Etoposide—uterine cancer	0.00899	0.0129	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—uterine cancer	0.00613	0.0088	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—uterine cancer	0.00578	0.00829	CbGbCtD
Amiodarone—CYP3A4—Etoposide—uterine cancer	0.00538	0.00773	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—uterine cancer	0.00367	0.00527	CbGbCtD
Amiodarone—EBP—uterine cervix—uterine cancer	0.00312	0.0551	CbGeAlD
Amiodarone—EBP—uterus—uterine cancer	0.0026	0.0459	CbGeAlD
Amiodarone—EBP—female reproductive system—uterine cancer	0.00234	0.0413	CbGeAlD
Amiodarone—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00212	1	CbGdCrCtD
Amiodarone—CACNA1H—myometrium—uterine cancer	0.00189	0.0335	CbGeAlD
Amiodarone—THRB—renal system—uterine cancer	0.00172	0.0304	CbGeAlD
Amiodarone—THRA—renal system—uterine cancer	0.00172	0.0304	CbGeAlD
Amiodarone—CACNA1H—smooth muscle tissue—uterine cancer	0.00143	0.0253	CbGeAlD
Amiodarone—THRA—female reproductive system—uterine cancer	0.00138	0.0243	CbGeAlD
Amiodarone—THRB—female reproductive system—uterine cancer	0.00138	0.0243	CbGeAlD
Amiodarone—THRA—female gonad—uterine cancer	0.00125	0.0221	CbGeAlD
Amiodarone—THRB—female gonad—uterine cancer	0.00125	0.0221	CbGeAlD
Amiodarone—THRB—vagina—uterine cancer	0.00125	0.022	CbGeAlD
Amiodarone—CACNA2D2—vagina—uterine cancer	0.00123	0.0218	CbGeAlD
Amiodarone—CACNA1H—uterus—uterine cancer	0.00123	0.0217	CbGeAlD
Amiodarone—CACNA1H—female reproductive system—uterine cancer	0.0011	0.0195	CbGeAlD
Amiodarone—SIGMAR1—myometrium—uterine cancer	0.00108	0.0191	CbGeAlD
Amiodarone—CACNA1H—female gonad—uterine cancer	0.00101	0.0178	CbGeAlD
Amiodarone—KCNH2—myometrium—uterine cancer	0.00086	0.0152	CbGeAlD
Amiodarone—SIGMAR1—uterine cervix—uterine cancer	0.000841	0.0149	CbGeAlD
Amiodarone—SIGMAR1—smooth muscle tissue—uterine cancer	0.000817	0.0144	CbGeAlD
Amiodarone—THRA—lymph node—uterine cancer	0.000805	0.0142	CbGeAlD
Amiodarone—THRB—lymph node—uterine cancer	0.000805	0.0142	CbGeAlD
Amiodarone—SIGMAR1—decidua—uterine cancer	0.000801	0.0142	CbGeAlD
Amiodarone—CACNA2D2—lymph node—uterine cancer	0.000797	0.0141	CbGeAlD
Amiodarone—SIGMAR1—endometrium—uterine cancer	0.000761	0.0134	CbGeAlD
Amiodarone—CYP2A6—vagina—uterine cancer	0.000739	0.0131	CbGeAlD
Amiodarone—SIGMAR1—mammalian vulva—uterine cancer	0.000736	0.013	CbGeAlD
Amiodarone—SIGMAR1—uterus—uterine cancer	0.000701	0.0124	CbGeAlD
Amiodarone—KCNH2—uterine cervix—uterine cancer	0.000669	0.0118	CbGeAlD
Amiodarone—ADRB1—female reproductive system—uterine cancer	0.000657	0.0116	CbGeAlD
Amiodarone—CACNA1H—lymph node—uterine cancer	0.000646	0.0114	CbGeAlD
Amiodarone—KCNH2—renal system—uterine cancer	0.000626	0.0111	CbGeAlD
Amiodarone—KCNH2—endometrium—uterine cancer	0.000605	0.0107	CbGeAlD
Amiodarone—SIGMAR1—female gonad—uterine cancer	0.000573	0.0101	CbGeAlD
Amiodarone—CYP2C8—renal system—uterine cancer	0.000573	0.0101	CbGeAlD
Amiodarone—CYP1A1—epithelium—uterine cancer	0.00057	0.0101	CbGeAlD
Amiodarone—SIGMAR1—vagina—uterine cancer	0.00057	0.0101	CbGeAlD
Amiodarone—CYP1A1—uterine cervix—uterine cancer	0.000565	0.00998	CbGeAlD
Amiodarone—KCNH2—uterus—uterine cancer	0.000558	0.00985	CbGeAlD
Amiodarone—CYP2C8—endometrium—uterine cancer	0.000554	0.00978	CbGeAlD
Amiodarone—CYP3A5—uterine cervix—uterine cancer	0.000553	0.00976	CbGeAlD
Amiodarone—CYP1A2—renal system—uterine cancer	0.000536	0.00947	CbGeAlD
Amiodarone—CYP1A1—renal system—uterine cancer	0.000529	0.00934	CbGeAlD
Amiodarone—CYP3A5—renal system—uterine cancer	0.000517	0.00913	CbGeAlD
Amiodarone—KCNH2—female reproductive system—uterine cancer	0.000502	0.00886	CbGeAlD
Amiodarone—CYP1A1—mammalian vulva—uterine cancer	0.000495	0.00874	CbGeAlD
Amiodarone—CYP2C19—vagina—uterine cancer	0.000476	0.0084	CbGeAlD
Amiodarone—CYP1A1—uterus—uterine cancer	0.000471	0.00832	CbGeAlD
Amiodarone—CYP2C8—female reproductive system—uterine cancer	0.000459	0.0081	CbGeAlD
Amiodarone—KCNH2—female gonad—uterine cancer	0.000456	0.00806	CbGeAlD
Amiodarone—KCNH2—vagina—uterine cancer	0.000454	0.00801	CbGeAlD
Amiodarone—CYP1A1—female reproductive system—uterine cancer	0.000424	0.00748	CbGeAlD
Amiodarone—CYP2C8—vagina—uterine cancer	0.000415	0.00733	CbGeAlD
Amiodarone—CYP2C9—female reproductive system—uterine cancer	0.000408	0.0072	CbGeAlD
Amiodarone—CYP3A4—renal system—uterine cancer	0.000388	0.00685	CbGeAlD
Amiodarone—CYP1A1—female gonad—uterine cancer	0.000385	0.00681	CbGeAlD
Amiodarone—CYP1A1—vagina—uterine cancer	0.000383	0.00677	CbGeAlD
Amiodarone—CYP2D6—renal system—uterine cancer	0.000382	0.00674	CbGeAlD
Amiodarone—ABCB1—myometrium—uterine cancer	0.000377	0.00666	CbGeAlD
Amiodarone—CYP3A5—female gonad—uterine cancer	0.000377	0.00666	CbGeAlD
Amiodarone—CYP3A5—vagina—uterine cancer	0.000375	0.00662	CbGeAlD
Amiodarone—SIGMAR1—lymph node—uterine cancer	0.000369	0.00651	CbGeAlD
Amiodarone—CYP3A4—female reproductive system—uterine cancer	0.000311	0.00549	CbGeAlD
Amiodarone—CYP2D6—female reproductive system—uterine cancer	0.000306	0.0054	CbGeAlD
Amiodarone—ABCB1—epithelium—uterine cancer	0.000296	0.00523	CbGeAlD
Amiodarone—ABCB1—uterine cervix—uterine cancer	0.000294	0.00519	CbGeAlD
Amiodarone—KCNH2—lymph node—uterine cancer	0.000293	0.00518	CbGeAlD
Amiodarone—ABCB1—decidua—uterine cancer	0.00028	0.00494	CbGeAlD
Amiodarone—CYP2D6—female gonad—uterine cancer	0.000278	0.00492	CbGeAlD
Amiodarone—ABCB1—renal system—uterine cancer	0.000275	0.00485	CbGeAlD
Amiodarone—ABCB1—endometrium—uterine cancer	0.000266	0.00469	CbGeAlD
Amiodarone—ABCB1—mammalian vulva—uterine cancer	0.000257	0.00454	CbGeAlD
Amiodarone—CYP1A1—lymph node—uterine cancer	0.000248	0.00438	CbGeAlD
Amiodarone—ABCB1—uterus—uterine cancer	0.000245	0.00432	CbGeAlD
Amiodarone—ABCB1—female reproductive system—uterine cancer	0.00022	0.00389	CbGeAlD
Amiodarone—Flushing—Etoposide—uterine cancer	0.000205	0.00112	CcSEcCtD
Amiodarone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000205	0.00112	CcSEcCtD
Amiodarone—Hepatic function abnormal—Epirubicin—uterine cancer	0.000205	0.00112	CcSEcCtD
Amiodarone—Photosensitivity—Epirubicin—uterine cancer	0.000204	0.00112	CcSEcCtD
Amiodarone—Pulmonary oedema—Doxorubicin—uterine cancer	0.000203	0.00111	CcSEcCtD
Amiodarone—Dizziness—Progesterone—uterine cancer	0.000203	0.00111	CcSEcCtD
Amiodarone—ABCB1—female gonad—uterine cancer	0.0002	0.00354	CbGeAlD
Amiodarone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0002	0.00109	CcSEcCtD
Amiodarone—Eczema—Epirubicin—uterine cancer	0.000199	0.00109	CcSEcCtD
Amiodarone—Hepatic failure—Epirubicin—uterine cancer	0.000199	0.00109	CcSEcCtD
Amiodarone—ABCB1—vagina—uterine cancer	0.000199	0.00351	CbGeAlD
Amiodarone—Cardiac failure congestive—Epirubicin—uterine cancer	0.000198	0.00108	CcSEcCtD
Amiodarone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00108	CcSEcCtD
Amiodarone—Alopecia—Etoposide—uterine cancer	0.000195	0.00107	CcSEcCtD
Amiodarone—Vomiting—Progesterone—uterine cancer	0.000195	0.00107	CcSEcCtD
Amiodarone—Renal failure acute—Epirubicin—uterine cancer	0.000194	0.00106	CcSEcCtD
Amiodarone—Rash—Progesterone—uterine cancer	0.000194	0.00106	CcSEcCtD
Amiodarone—Dermatitis—Progesterone—uterine cancer	0.000194	0.00106	CcSEcCtD
Amiodarone—Phlebitis—Doxorubicin—uterine cancer	0.000192	0.00105	CcSEcCtD
Amiodarone—Headache—Progesterone—uterine cancer	0.000192	0.00105	CcSEcCtD
Amiodarone—Hot flush—Epirubicin—uterine cancer	0.000192	0.00105	CcSEcCtD
Amiodarone—Thrombophlebitis—Doxorubicin—uterine cancer	0.000192	0.00105	CcSEcCtD
Amiodarone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00019	0.00104	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00019	0.00104	CcSEcCtD
Amiodarone—Menopausal symptoms—Epirubicin—uterine cancer	0.00019	0.00104	CcSEcCtD
Amiodarone—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00019	0.00104	CcSEcCtD
Amiodarone—Photosensitivity—Doxorubicin—uterine cancer	0.000189	0.00103	CcSEcCtD
Amiodarone—Decreased appetite—Dactinomycin—uterine cancer	0.000189	0.00103	CcSEcCtD
Amiodarone—Dysgeusia—Etoposide—uterine cancer	0.000189	0.00103	CcSEcCtD
Amiodarone—Renal impairment—Epirubicin—uterine cancer	0.000188	0.00103	CcSEcCtD
Amiodarone—Fatigue—Dactinomycin—uterine cancer	0.000187	0.00103	CcSEcCtD
Amiodarone—Back pain—Etoposide—uterine cancer	0.000186	0.00102	CcSEcCtD
Amiodarone—Pain—Dactinomycin—uterine cancer	0.000186	0.00102	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Amiodarone—Hepatic failure—Doxorubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Amiodarone—Eczema—Doxorubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Amiodarone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000184	0.00101	CcSEcCtD
Amiodarone—Cardiac failure—Epirubicin—uterine cancer	0.000184	0.00101	CcSEcCtD
Amiodarone—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000183	0.001	CcSEcCtD
Amiodarone—Nausea—Progesterone—uterine cancer	0.000182	0.001	CcSEcCtD
Amiodarone—Renal failure acute—Doxorubicin—uterine cancer	0.00018	0.000984	CcSEcCtD
Amiodarone—Feeling abnormal—Dactinomycin—uterine cancer	0.000179	0.00098	CcSEcCtD
Amiodarone—Ill-defined disorder—Etoposide—uterine cancer	0.000179	0.000979	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000178	0.000973	CcSEcCtD
Amiodarone—Hot flush—Doxorubicin—uterine cancer	0.000177	0.000971	CcSEcCtD
Amiodarone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000177	0.00097	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000176	0.000963	CcSEcCtD
Amiodarone—Menopausal symptoms—Doxorubicin—uterine cancer	0.000176	0.000963	CcSEcCtD
Amiodarone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000176	0.000962	CcSEcCtD
Amiodarone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000175	0.000961	CcSEcCtD
Amiodarone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000174	0.000956	CcSEcCtD
Amiodarone—Renal impairment—Doxorubicin—uterine cancer	0.000174	0.000955	CcSEcCtD
Amiodarone—Malaise—Etoposide—uterine cancer	0.000174	0.000952	CcSEcCtD
Amiodarone—Vertigo—Etoposide—uterine cancer	0.000173	0.000948	CcSEcCtD
Amiodarone—Body temperature increased—Dactinomycin—uterine cancer	0.000172	0.000941	CcSEcCtD
Amiodarone—Abdominal pain—Dactinomycin—uterine cancer	0.000172	0.000941	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000171	0.000939	CcSEcCtD
Amiodarone—Cardiac arrest—Epirubicin—uterine cancer	0.00017	0.000934	CcSEcCtD
Amiodarone—Cardiac failure—Doxorubicin—uterine cancer	0.00017	0.000931	CcSEcCtD
Amiodarone—Ataxia—Epirubicin—uterine cancer	0.000169	0.000923	CcSEcCtD
Amiodarone—Cough—Etoposide—uterine cancer	0.000168	0.000921	CcSEcCtD
Amiodarone—Liver function test abnormal—Epirubicin—uterine cancer	0.000165	0.000907	CcSEcCtD
Amiodarone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000165	0.000906	CcSEcCtD
Amiodarone—Discomfort—Etoposide—uterine cancer	0.000162	0.000888	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000161	0.000884	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000161	0.000884	CcSEcCtD
Amiodarone—Hypersensitivity—Dactinomycin—uterine cancer	0.00016	0.000877	CcSEcCtD
Amiodarone—Confusional state—Etoposide—uterine cancer	0.000158	0.000868	CcSEcCtD
Amiodarone—Muscular weakness—Epirubicin—uterine cancer	0.000158	0.000866	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000158	0.000866	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—uterine cancer	0.000158	0.000864	CcSEcCtD
Amiodarone—Anaphylactic shock—Etoposide—uterine cancer	0.000157	0.000861	CcSEcCtD
Amiodarone—Infection—Etoposide—uterine cancer	0.000156	0.000856	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—uterine cancer	0.000156	0.000854	CcSEcCtD
Amiodarone—Asthenia—Dactinomycin—uterine cancer	0.000156	0.000854	CcSEcCtD
Amiodarone—Thrombocytopenia—Etoposide—uterine cancer	0.000154	0.000843	CcSEcCtD
Amiodarone—Tachycardia—Etoposide—uterine cancer	0.000153	0.00084	CcSEcCtD
Amiodarone—Eosinophilia—Epirubicin—uterine cancer	0.000153	0.00084	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—uterine cancer	0.000153	0.000839	CcSEcCtD
Amiodarone—Skin disorder—Etoposide—uterine cancer	0.000153	0.000836	CcSEcCtD
Amiodarone—Hyperhidrosis—Etoposide—uterine cancer	0.000152	0.000832	CcSEcCtD
Amiodarone—Pancreatitis—Epirubicin—uterine cancer	0.000152	0.000832	CcSEcCtD
Amiodarone—Angina pectoris—Epirubicin—uterine cancer	0.000151	0.000827	CcSEcCtD
Amiodarone—Anorexia—Etoposide—uterine cancer	0.00015	0.000821	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000149	0.000818	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000149	0.000818	CcSEcCtD
Amiodarone—Diarrhoea—Dactinomycin—uterine cancer	0.000149	0.000814	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—uterine cancer	0.000147	0.000806	CcSEcCtD
Amiodarone—Hypotension—Etoposide—uterine cancer	0.000147	0.000805	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000146	0.000801	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—uterine cancer	0.000146	0.000801	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—uterine cancer	0.000145	0.000794	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—uterine cancer	0.000142	0.000778	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—uterine cancer	0.000141	0.000775	CcSEcCtD
Amiodarone—Paraesthesia—Etoposide—uterine cancer	0.000141	0.000773	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—uterine cancer	0.000141	0.000773	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—uterine cancer	0.000141	0.00077	CcSEcCtD
Amiodarone—Weight decreased—Epirubicin—uterine cancer	0.00014	0.000768	CcSEcCtD
Amiodarone—Dyspnoea—Etoposide—uterine cancer	0.00014	0.000768	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—uterine cancer	0.00014	0.000765	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—uterine cancer	0.000139	0.000761	CcSEcCtD
Amiodarone—Vomiting—Dactinomycin—uterine cancer	0.000138	0.000757	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000137	0.00075	CcSEcCtD
Amiodarone—Rash—Dactinomycin—uterine cancer	0.000137	0.00075	CcSEcCtD
Amiodarone—Decreased appetite—Etoposide—uterine cancer	0.000137	0.000749	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—uterine cancer	0.000136	0.000746	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—uterine cancer	0.000136	0.000744	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000136	0.000743	CcSEcCtD
Amiodarone—Fatigue—Etoposide—uterine cancer	0.000135	0.000742	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—uterine cancer	0.000135	0.000742	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—uterine cancer	0.000135	0.000738	CcSEcCtD
Amiodarone—Constipation—Etoposide—uterine cancer	0.000134	0.000736	CcSEcCtD
Amiodarone—Pain—Etoposide—uterine cancer	0.000134	0.000736	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—uterine cancer	0.000134	0.000734	CcSEcCtD
Amiodarone—Sweating—Epirubicin—uterine cancer	0.000132	0.000726	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000131	0.000717	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—uterine cancer	0.00013	0.000715	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—uterine cancer	0.00013	0.000711	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—uterine cancer	0.000129	0.00071	CcSEcCtD
Amiodarone—Nausea—Dactinomycin—uterine cancer	0.000129	0.000707	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—uterine cancer	0.000129	0.000706	CcSEcCtD
Amiodarone—ABCB1—lymph node—uterine cancer	0.000129	0.00227	CbGeAlD
Amiodarone—Pneumonia—Doxorubicin—uterine cancer	0.000129	0.000704	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—uterine cancer	0.000129	0.000704	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000127	0.000694	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—uterine cancer	0.000126	0.000692	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—uterine cancer	0.000126	0.000688	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000125	0.000686	CcSEcCtD
Amiodarone—Urticaria—Etoposide—uterine cancer	0.000125	0.000684	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—uterine cancer	0.000125	0.000683	CcSEcCtD
Amiodarone—Abdominal pain—Etoposide—uterine cancer	0.000124	0.000681	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—uterine cancer	0.000124	0.000681	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—uterine cancer	0.000124	0.000679	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—uterine cancer	0.000123	0.000671	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—uterine cancer	0.000119	0.000655	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—uterine cancer	0.000119	0.000654	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—uterine cancer	0.000117	0.000642	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—uterine cancer	0.000117	0.00064	CcSEcCtD
Amiodarone—Hypersensitivity—Etoposide—uterine cancer	0.000116	0.000634	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—uterine cancer	0.000116	0.000633	CcSEcCtD
Amiodarone—Flushing—Epirubicin—uterine cancer	0.000115	0.000631	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—uterine cancer	0.000115	0.000629	CcSEcCtD
Amiodarone—Asthenia—Etoposide—uterine cancer	0.000113	0.000618	CcSEcCtD
Amiodarone—Pruritus—Etoposide—uterine cancer	0.000111	0.000609	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—uterine cancer	0.000111	0.000607	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—uterine cancer	0.000111	0.000606	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—uterine cancer	0.00011	0.0006	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—uterine cancer	0.000108	0.000594	CcSEcCtD
Amiodarone—Erythema—Epirubicin—uterine cancer	0.000108	0.000591	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—uterine cancer	0.000108	0.000589	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—uterine cancer	0.000107	0.000586	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—uterine cancer	0.000106	0.000583	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—uterine cancer	0.000106	0.000579	CcSEcCtD
Amiodarone—Back pain—Epirubicin—uterine cancer	0.000104	0.000572	CcSEcCtD
Amiodarone—Dizziness—Etoposide—uterine cancer	0.000104	0.000569	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—uterine cancer	0.000102	0.000562	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—uterine cancer	0.000102	0.000557	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—uterine cancer	0.000101	0.000556	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—uterine cancer	0.0001	0.000549	CcSEcCtD
Amiodarone—Vomiting—Etoposide—uterine cancer	9.99e-05	0.000548	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—uterine cancer	9.99e-05	0.000547	CcSEcCtD
Amiodarone—Agitation—Epirubicin—uterine cancer	9.92e-05	0.000544	CcSEcCtD
Amiodarone—Rash—Etoposide—uterine cancer	9.91e-05	0.000543	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—uterine cancer	9.9e-05	0.000542	CcSEcCtD
Amiodarone—Headache—Etoposide—uterine cancer	9.84e-05	0.000539	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—uterine cancer	9.78e-05	0.000536	CcSEcCtD
Amiodarone—Malaise—Epirubicin—uterine cancer	9.73e-05	0.000533	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—uterine cancer	9.7e-05	0.000531	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—uterine cancer	9.66e-05	0.000529	CcSEcCtD
Amiodarone—Cough—Epirubicin—uterine cancer	9.42e-05	0.000516	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—uterine cancer	9.41e-05	0.000516	CcSEcCtD
Amiodarone—Nausea—Etoposide—uterine cancer	9.33e-05	0.000512	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—uterine cancer	9.27e-05	0.000508	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—uterine cancer	9.18e-05	0.000503	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—uterine cancer	9.16e-05	0.000502	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—uterine cancer	9.08e-05	0.000498	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—uterine cancer	9.01e-05	0.000494	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—uterine cancer	8.99e-05	0.000492	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—uterine cancer	8.97e-05	0.000492	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—uterine cancer	8.88e-05	0.000487	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—uterine cancer	8.81e-05	0.000483	CcSEcCtD
Amiodarone—Oedema—Epirubicin—uterine cancer	8.81e-05	0.000483	CcSEcCtD
Amiodarone—Infection—Epirubicin—uterine cancer	8.75e-05	0.00048	CcSEcCtD
Amiodarone—Cough—Doxorubicin—uterine cancer	8.71e-05	0.000478	CcSEcCtD
Amiodarone—Shock—Epirubicin—uterine cancer	8.67e-05	0.000475	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—uterine cancer	8.62e-05	0.000473	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—uterine cancer	8.6e-05	0.000471	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—uterine cancer	8.56e-05	0.000469	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—uterine cancer	8.52e-05	0.000467	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—uterine cancer	8.47e-05	0.000464	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—uterine cancer	8.4e-05	0.00046	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—uterine cancer	8.4e-05	0.00046	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—uterine cancer	8.32e-05	0.000456	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—uterine cancer	8.23e-05	0.000451	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—uterine cancer	8.22e-05	0.00045	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—uterine cancer	8.15e-05	0.000447	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—uterine cancer	8.15e-05	0.000447	CcSEcCtD
Amiodarone—Infection—Doxorubicin—uterine cancer	8.1e-05	0.000444	CcSEcCtD
Amiodarone—Shock—Doxorubicin—uterine cancer	8.02e-05	0.000439	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—uterine cancer	7.98e-05	0.000437	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—uterine cancer	7.97e-05	0.000437	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—uterine cancer	7.95e-05	0.000436	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—uterine cancer	7.92e-05	0.000434	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—uterine cancer	7.91e-05	0.000433	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—uterine cancer	7.88e-05	0.000432	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—uterine cancer	7.85e-05	0.00043	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—uterine cancer	7.77e-05	0.000426	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—uterine cancer	7.75e-05	0.000425	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—uterine cancer	7.66e-05	0.00042	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—uterine cancer	7.62e-05	0.000417	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—uterine cancer	7.61e-05	0.000417	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—uterine cancer	7.59e-05	0.000416	CcSEcCtD
Amiodarone—Pain—Epirubicin—uterine cancer	7.53e-05	0.000413	CcSEcCtD
Amiodarone—Constipation—Epirubicin—uterine cancer	7.53e-05	0.000413	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—uterine cancer	7.37e-05	0.000404	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—uterine cancer	7.32e-05	0.000401	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—uterine cancer	7.27e-05	0.000398	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—uterine cancer	7.26e-05	0.000398	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—uterine cancer	7.2e-05	0.000395	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—uterine cancer	7.17e-05	0.000393	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—uterine cancer	7.09e-05	0.000388	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—uterine cancer	7.04e-05	0.000386	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—uterine cancer	7.03e-05	0.000385	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—uterine cancer	7e-05	0.000383	CcSEcCtD
Amiodarone—Pain—Doxorubicin—uterine cancer	6.97e-05	0.000382	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—uterine cancer	6.97e-05	0.000382	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—uterine cancer	6.96e-05	0.000382	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—uterine cancer	6.96e-05	0.000382	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—uterine cancer	6.72e-05	0.000368	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—uterine cancer	6.67e-05	0.000365	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—uterine cancer	6.49e-05	0.000356	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—uterine cancer	6.48e-05	0.000355	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—uterine cancer	6.44e-05	0.000353	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—uterine cancer	6.44e-05	0.000353	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—uterine cancer	6.32e-05	0.000346	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—uterine cancer	6.23e-05	0.000342	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—uterine cancer	6.03e-05	0.00033	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—uterine cancer	6.01e-05	0.000329	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—uterine cancer	5.85e-05	0.00032	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—uterine cancer	5.83e-05	0.000319	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—uterine cancer	5.77e-05	0.000316	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—uterine cancer	5.6e-05	0.000307	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—uterine cancer	5.58e-05	0.000306	CcSEcCtD
Amiodarone—Rash—Epirubicin—uterine cancer	5.55e-05	0.000304	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—uterine cancer	5.55e-05	0.000304	CcSEcCtD
Amiodarone—Headache—Epirubicin—uterine cancer	5.52e-05	0.000302	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—uterine cancer	5.39e-05	0.000295	CcSEcCtD
Amiodarone—Nausea—Epirubicin—uterine cancer	5.23e-05	0.000287	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—uterine cancer	5.18e-05	0.000284	CcSEcCtD
Amiodarone—Rash—Doxorubicin—uterine cancer	5.14e-05	0.000282	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—uterine cancer	5.13e-05	0.000281	CcSEcCtD
Amiodarone—Headache—Doxorubicin—uterine cancer	5.11e-05	0.00028	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—uterine cancer	4.84e-05	0.000265	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—AKT1—uterine cancer	2.47e-05	0.000395	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—POLD1—uterine cancer	2.47e-05	0.000395	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.46e-05	0.000394	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—INHBA—uterine cancer	2.45e-05	0.000393	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.44e-05	0.000391	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.44e-05	0.000391	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.43e-05	0.00039	CbGpPWpGaD
Amiodarone—EBP—Metabolism—EP300—uterine cancer	2.42e-05	0.000388	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.42e-05	0.000387	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.42e-05	0.000387	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.35e-05	0.000376	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKR1B1—uterine cancer	2.34e-05	0.000375	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—STAR—uterine cancer	2.34e-05	0.000375	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	2.32e-05	0.000371	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.32e-05	0.000371	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKR1C1—uterine cancer	2.31e-05	0.00037	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—RRM2—uterine cancer	2.24e-05	0.00036	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.22e-05	0.000355	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKR1C1—uterine cancer	2.21e-05	0.000354	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—DCN—uterine cancer	2.18e-05	0.000349	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.17e-05	0.000348	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.15e-05	0.000344	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—STAR—uterine cancer	2.15e-05	0.000344	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.12e-05	0.00034	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.07e-05	0.000331	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.07e-05	0.000331	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—RRM2—uterine cancer	2.06e-05	0.00033	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP11A1—uterine cancer	2.05e-05	0.000329	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CXCL8—uterine cancer	2.03e-05	0.000326	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.01e-05	0.000322	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.01e-05	0.000322	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—DCN—uterine cancer	2e-05	0.00032	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—POLD1—uterine cancer	1.95e-05	0.000312	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.94e-05	0.000311	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—STAR—uterine cancer	1.92e-05	0.000307	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.92e-05	0.000307	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.9e-05	0.000304	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.9e-05	0.000304	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.89e-05	0.000304	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.88e-05	0.000301	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKR1B1—uterine cancer	1.87e-05	0.0003	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—STAR—uterine cancer	1.87e-05	0.0003	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.85e-05	0.000297	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—POLD1—uterine cancer	1.84e-05	0.000295	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.82e-05	0.000292	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PTEN—uterine cancer	1.81e-05	0.00029	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PIK3CA—uterine cancer	1.79e-05	0.000287	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.78e-05	0.000285	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.77e-05	0.000283	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.76e-05	0.000283	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—STAR—uterine cancer	1.76e-05	0.000283	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.75e-05	0.00028	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—STAR—uterine cancer	1.75e-05	0.00028	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.73e-05	0.000277	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—EP300—uterine cancer	1.72e-05	0.000276	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—AKT1—uterine cancer	1.72e-05	0.000276	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—AKT1—uterine cancer	1.72e-05	0.000276	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.72e-05	0.000276	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKR1C3—uterine cancer	1.7e-05	0.000272	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—POLD1—uterine cancer	1.69e-05	0.00027	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.67e-05	0.000268	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PGR—uterine cancer	1.66e-05	0.000266	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—RRM2—uterine cancer	1.62e-05	0.00026	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.59e-05	0.000255	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.59e-05	0.000255	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—YWHAE—uterine cancer	1.58e-05	0.000253	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.58e-05	0.000253	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—DCN—uterine cancer	1.57e-05	0.000252	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—RRM2—uterine cancer	1.53e-05	0.000246	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FBXW7—uterine cancer	1.52e-05	0.000243	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.51e-05	0.000242	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—STK11—uterine cancer	1.51e-05	0.000242	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—POLD1—uterine cancer	1.5e-05	0.000241	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.49e-05	0.000239	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—STAR—uterine cancer	1.49e-05	0.000239	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—DCN—uterine cancer	1.49e-05	0.000238	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.48e-05	0.000238	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.48e-05	0.000237	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—POLD1—uterine cancer	1.47e-05	0.000235	CbGpPWpGaD
Amiodarone—EBP—Metabolism—AKT1—uterine cancer	1.46e-05	0.000234	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.42e-05	0.000228	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.41e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—RRM2—uterine cancer	1.41e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.4e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.4e-05	0.000224	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—STK11—uterine cancer	1.38e-05	0.000222	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.38e-05	0.000222	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—POLD1—uterine cancer	1.38e-05	0.000222	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKR1C1—uterine cancer	1.37e-05	0.00022	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—POLD1—uterine cancer	1.37e-05	0.00022	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—DCN—uterine cancer	1.36e-05	0.000219	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STK11—uterine cancer	1.32e-05	0.000212	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.32e-05	0.000212	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCL2—uterine cancer	1.32e-05	0.000211	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.31e-05	0.000209	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.29e-05	0.000207	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.29e-05	0.000206	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.28e-05	0.000206	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PIK3CA—uterine cancer	1.28e-05	0.000204	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.26e-05	0.000202	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—RRM2—uterine cancer	1.25e-05	0.000201	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SOCS3—uterine cancer	1.24e-05	0.000199	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—RRM2—uterine cancer	1.22e-05	0.000196	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—DCN—uterine cancer	1.22e-05	0.000195	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.21e-05	0.000194	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—DCN—uterine cancer	1.19e-05	0.00019	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN2B—uterine cancer	1.19e-05	0.00019	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—POLD1—uterine cancer	1.17e-05	0.000188	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—RRM2—uterine cancer	1.15e-05	0.000185	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1R—uterine cancer	1.15e-05	0.000185	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—STAR—uterine cancer	1.15e-05	0.000185	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.15e-05	0.000185	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—uterine cancer	1.15e-05	0.000184	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.15e-05	0.000184	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—RRM2—uterine cancer	1.14e-05	0.000183	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—MTHFR—uterine cancer	1.13e-05	0.000182	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—DCN—uterine cancer	1.12e-05	0.000179	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP11A1—uterine cancer	1.12e-05	0.000179	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—DCN—uterine cancer	1.11e-05	0.000178	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.1e-05	0.000176	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.09e-05	0.000175	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—STK11—uterine cancer	1.09e-05	0.000175	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SMAD3—uterine cancer	1.08e-05	0.000174	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.08e-05	0.000174	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.07e-05	0.000171	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000169	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.06e-05	0.000169	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.05e-05	0.000168	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—uterine cancer	1.04e-05	0.000167	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—uterine cancer	1.04e-05	0.000167	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—MTHFR—uterine cancer	1.04e-05	0.000167	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGFR2—uterine cancer	1.03e-05	0.000166	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—STK11—uterine cancer	1.03e-05	0.000165	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.03e-05	0.000165	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKR1C3—uterine cancer	9.96e-06	0.00016	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKR1C3—uterine cancer	9.88e-06	0.000158	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—RRM2—uterine cancer	9.77e-06	0.000157	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.68e-06	0.000155	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—DCN—uterine cancer	9.49e-06	0.000152	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—STK11—uterine cancer	9.45e-06	0.000151	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP19A1—uterine cancer	9.45e-06	0.000151	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.23e-06	0.000148	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—POLD1—uterine cancer	9.05e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP11A1—uterine cancer	8.94e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.88e-06	0.000142	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ESR1—uterine cancer	8.85e-06	0.000142	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.46e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKR1C1—uterine cancer	8.46e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKR1C3—uterine cancer	8.44e-06	0.000135	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP19A1—uterine cancer	8.44e-06	0.000135	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—STK11—uterine cancer	8.44e-06	0.000135	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—uterine cancer	8.36e-06	0.000134	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP19A1—uterine cancer	8.24e-06	0.000132	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—STK11—uterine cancer	8.24e-06	0.000132	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—MTHFR—uterine cancer	8.2e-06	0.000131	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.92e-06	0.000127	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL2—uterine cancer	7.79e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—STK11—uterine cancer	7.76e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP19A1—uterine cancer	7.76e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—MTHFR—uterine cancer	7.75e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—STK11—uterine cancer	7.69e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP19A1—uterine cancer	7.69e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.55e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—RRM2—uterine cancer	7.54e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—DCN—uterine cancer	7.32e-06	0.000117	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—uterine cancer	7.28e-06	0.000117	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.22e-06	0.000116	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—uterine cancer	7.2e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MTHFR—uterine cancer	7.1e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.9e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.89e-06	0.00011	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.83e-06	0.000109	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—uterine cancer	6.61e-06	0.000106	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP19A1—uterine cancer	6.58e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—STK11—uterine cancer	6.58e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.51e-06	0.000104	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—uterine cancer	6.5e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MTHFR—uterine cancer	6.34e-06	0.000102	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—uterine cancer	6.31e-06	0.000101	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.26e-06	0.0001	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MTHFR—uterine cancer	6.19e-06	9.92e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.17e-06	9.89e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—uterine cancer	6.16e-06	9.87e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—uterine cancer	6.12e-06	9.8e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—EP300—uterine cancer	6.02e-06	9.65e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—uterine cancer	6.02e-06	9.64e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—uterine cancer	5.95e-06	9.53e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.89e-06	9.43e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MTHFR—uterine cancer	5.83e-06	9.35e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—uterine cancer	5.79e-06	9.27e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MTHFR—uterine cancer	5.78e-06	9.26e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—uterine cancer	5.68e-06	9.1e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.59e-06	8.95e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—uterine cancer	5.54e-06	8.87e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—EP300—uterine cancer	5.52e-06	8.84e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—uterine cancer	5.4e-06	8.66e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EP300—uterine cancer	5.28e-06	8.46e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.1e-06	8.16e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—STK11—uterine cancer	5.07e-06	8.13e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.07e-06	8.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—uterine cancer	5e-06	8.02e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—uterine cancer	4.94e-06	7.92e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MTHFR—uterine cancer	4.94e-06	7.92e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—uterine cancer	4.56e-06	7.31e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—uterine cancer	4.45e-06	7.14e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.35e-06	6.98e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—EP300—uterine cancer	4.35e-06	6.97e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—uterine cancer	4.31e-06	6.91e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—uterine cancer	4.25e-06	6.81e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—EP300—uterine cancer	4.11e-06	6.59e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—uterine cancer	4.08e-06	6.54e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—uterine cancer	3.95e-06	6.33e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—uterine cancer	3.91e-06	6.26e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTHFR—uterine cancer	3.81e-06	6.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—uterine cancer	3.78e-06	6.06e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—EP300—uterine cancer	3.77e-06	6.04e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—uterine cancer	3.64e-06	5.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—uterine cancer	3.62e-06	5.79e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—uterine cancer	3.53e-06	5.65e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—uterine cancer	3.44e-06	5.52e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—EP300—uterine cancer	3.36e-06	5.39e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—uterine cancer	3.33e-06	5.34e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—EP300—uterine cancer	3.28e-06	5.26e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—uterine cancer	3.24e-06	5.2e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.22e-06	5.16e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—uterine cancer	3.22e-06	5.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—uterine cancer	3.19e-06	5.11e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—EP300—uterine cancer	3.09e-06	4.96e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—EP300—uterine cancer	3.07e-06	4.92e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—uterine cancer	3.04e-06	4.87e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.79e-06	4.47e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—uterine cancer	2.75e-06	4.4e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—uterine cancer	2.63e-06	4.21e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—EP300—uterine cancer	2.62e-06	4.2e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.49e-06	3.99e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—uterine cancer	2.48e-06	3.98e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—uterine cancer	2.43e-06	3.89e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.29e-06	3.67e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—uterine cancer	2.28e-06	3.65e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.27e-06	3.64e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—uterine cancer	2.12e-06	3.4e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—uterine cancer	2.03e-06	3.26e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—EP300—uterine cancer	2.02e-06	3.24e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—uterine cancer	1.98e-06	3.18e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.94e-06	3.11e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—uterine cancer	1.87e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—uterine cancer	1.85e-06	2.97e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—uterine cancer	1.58e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.5e-06	2.4e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—uterine cancer	1.22e-06	1.96e-05	CbGpPWpGaD
